BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/18/2025 6:26:37 AM | Browse: 51 | Download: 0
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Hong-Yu Ma, Xin Liu, Yuan-Wu Chen, Jing Liang, Jie Wang, Ming-Ming Zhang and Qian Yang |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Scientific Research Project of Hebei Administration of Traditional Chinese Medicine |
2025271 |
the Construction Project of National Clinical Research Base of Traditional Chinese Medicine, Science Letter[2018] |
131 |
Natural Science Foundation of Hebei Province |
H2023423001 |
Key Research Project of the Ministry of Science and Technology |
2018YFC1704100 and 2018YFC1704102 |
Provincial Science and Technology Program of Hebei Province |
21377724D and 21377740D |
Scientific Research Project of Hebei Administration of Traditional Chinese Medicine |
2021034, 2022026, 2022032, and 2023022 |
Medical Science Research Project of Hebei Province |
20190756 |
|
Corresponding Author |
Qian Yang, Department of Spleen and Stomach Diseases, First Affiliated Hospital of Hebei University of Chinese Medicine, Shijiazhuang 050011, Hebei Province, China. yang0311qian@126.com |
Key Words |
Baohe Pingwei powder; Neoadjuvant chemotherapy; Gastric cancer; Security; Effectiveness |
Core Tip |
Baohe Pingwei powder, when combined with neoadjuvant chemotherapy, exhibits significant efficacy in post-gastrectomy cancer patients. This study reveals that the addition of Baohe Pingwei powder enhances treatment outcomes, improves immune function, and reduces adverse reactions compared to chemotherapy alone. The most innovative finding is the powder's ability to prolong recurrence-free survival, highlighting its potential as an adjuvant therapy for gastric cancer patients undergoing surgery. |
Citation |
Ma HY, Liu X, Chen YW, Liang J, Wang J, Yang Q, Zhang MM. Baohe Pingwei power plus neoadjuvant chemotherapy for gastric cancer. World J Gastrointest Surg 2025; In press |
 |
Received |
|
2025-03-05 07:53 |
 |
Peer-Review Started |
|
2025-03-05 07:53 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-21 06:56 |
 |
Revised |
|
2025-03-25 06:11 |
 |
Second Decision |
|
2025-04-18 02:42 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-04-18 06:26 |
 |
Articles in Press |
|
2025-04-18 06:26 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-9366 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345